CORRECTION FROM SOURCE: Swiss Medica Plans To Offer Family Of Patented, Clinically Tested And Natural Products To Treat Symptoms Of Depression.TORONTO -- The following corrects and replaces the release sent on April 6, 2005 @ 9:09 AM ET. Swiss Medica's newly acquired Anti-Depression BioHealth Solutions Inc. will enable Swiss Medica medica (māˑ·dē·k to follow the successful U.S. launch of the company's flagship product A primary product of a company, which is typically why the company was founded and/or what made it well known. For example, MS-DOS, Windows and the Microsoft Office suite have been flagship products of Microsoft. CorelDRAW is a flagship product of Corel Corporation. , O24 Essential Oil Pain Neutralizer neu·tral·ize tr.v. neu·tral·ized, neu·tral·iz·ing, neu·tral·iz·es 1. To make neutral. 2. To counterbalance or counteract the effect of; render ineffective. 3. , by offering US-patented, clinically tested and natural products to treat the symptoms associated with depression, such as mood problems. These new products will be launched using the same marketing formula which has dramatically increased quarter-to-quarter revenues over the past year. The products emanating from Anti-Depression BioHealth Solutions Inc. will address the needs of a $17 billion market. More than 28 million Americans, or one in ten, have sought or are seeking a solution to treat the symptoms associated with depression. "This is a tremendous opportunity for Swiss Medica because the size of the market is enormous. We have begun making our imprint for the all natural and clinically proven O24 during our extensive U.S. media campaign to support nationwide distribution", announced CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. Raghu Kilambi. "It is a logical step to capitalize upon the marketing and distribution inroads inroads Noun, pl make inroads into to start affecting or reducing: my gambling has made great inroads into my savings inroads npl to make inroads into [+ our management has made over the past year, with a family of new products that we believe will also broadly appeal to a large segment of consumers, and which is consistent with our mission statement of commercializing proprietary bioscience products that relieve chronic ailments." The cost to the U.S. economy of symptoms associated with depression has been estimated at more than $43 billion, and approximately 200 million workdays are lost yearly. Many prescription treatments for symptoms associated with depression come with significant side effects Side effects Effects of a proposed project on other parts of the firm. . Swiss Medica hopes its all natural approach will have the same success that its flagship product, O24, has had at dealing with muscle and joint pain. "We hope that providing an effective natural remedy to help consumers overcome the symptoms associated with depression will become as welcome as our present acceptance of O24", said Mr. Kilambi. About Swiss Medica Inc. Swiss Medica commercializes proprietary bioscience products that relieve chronic ailments. We increase our market share through focused distribution strategies in multiple sales channels. Swiss Medica's mission is to be a world leader in the commercialization of life enhancing bioscience products that improve quality of lives. Please visit our websites at www.swissmedica.com and www.O24zone.com Swiss Medica's flagship product, the O24 Essential Oil Pain Neutralizer, holds US Patent #6,444,238B1. The O24 pain relief solution has been used, recommended and praised for its fast-acting and long-lasting benefits by healthcare professionals in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. , Canada and in Europe. O24 is widely available throughout Canada in leading pharmacies and natural food stores. It is currently sold in an increasing number of pharmacies throughout the United States. Customers can also visit www.O24zone.com, for ordering details and store locators for the nearest pharmacy. Forward-looking statements in this news release are made pursuant to the "Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. " provisions of the United States Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, risks relating to relating to relate prep → concernant relating to relate prep → bezüglich +gen, mit Bezug auf +acc the ability to close transactions being contemplated, risks related to international sales and potential foreign currency exchange fluctuations, continued acceptance of Swiss Medica's products, increased levels of competition, technological changes, dependence on intellectual property rights and other risks detailed from time to time in Swiss Medica's periodic reports filed with the United States Securities and Exchange Commission and other regulatory authorities. Swiss Medica Inc. (OTC Bulletin Board OTC Bulletin Board An electronic quotation listing of the bid and asked prices of OTC stocks that do not meet the requirements to be listed on the NASDAQ stock-listing system. :SWME) |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion